Nuvalent, Inc. - Class A Common Stock (NUVL)
85.81
-1.94 (-2.21%)
Nuvalent Inc is a biopharmaceutical company focused on developing targeted therapies for patients with cancer
The company specializes in creating innovative drug candidates that aim to effectively treat specific types of tumors by addressing the underlying genetic mechanisms driving disease progression. By leveraging advanced science and technology, Nuvalent strives to improve treatment options and outcomes for patients with difficult-to-treat cancers, emphasizing precision medicine to enhance the efficacy and safety of oncology treatments.
Frequently Asked Questions
Is Nuvalent, Inc. - Class A Common Stock publicly traded?
Yes, Nuvalent, Inc. - Class A Common Stock is publicly traded.
What exchange does Nuvalent, Inc. - Class A Common Stock trade on?
Nuvalent, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nuvalent, Inc. - Class A Common Stock?
The ticker symbol for Nuvalent, Inc. - Class A Common Stock is NUVL on the Nasdaq Stock Market
What is the current price of Nuvalent, Inc. - Class A Common Stock?
The current price of Nuvalent, Inc. - Class A Common Stock is 85.81
When was Nuvalent, Inc. - Class A Common Stock last traded?
The last trade of Nuvalent, Inc. - Class A Common Stock was at 4:00 pm EST on January 31st, 2025